HomeNewsBusinessCompaniesExclusive | Leading Fortis shareholder against Munjal-Burman's offer, cites low valuation
Trending Topics

Exclusive | Leading Fortis shareholder against Munjal-Burman's offer, cites low valuation

“Yes, chances are high that we may vote against the decision,” the person representing the shareholder said.

May 11, 2018 / 19:04 IST
Story continues below Advertisement

Beena Parmar and Viswanath Pilla Moneycontrol News

A leading institutional shareholder of Fortis Healthcare on Friday said it may vote against the Munjal-Burmans offer if it is tabled before shareholders for approval.

“We are unhappy. Had it been a really good offer, the share price would have shot up,” said a person representing the shareholder, who did not wish to be named.

Story continues below Advertisement

Shares of Fortis declined 2.66 percent to close at Rs 148.40 on BSE on Friday.

The Fortis board on Thursday backed the offer proposed by the Munjal-Burmans for the healthcare chain’s hospital and diagnostics businesses.
Sunil Munjal-led Hero Enterprise and Dabur's Anand Burman and Mohit Burman have jointly offered to invest Rs 1,800 crore in Fortis Healthcare, of which Rs 800 crore will be through a preferential allotment of equity shares at Rs 167 apiece.